Transcript Document

Impact of Technology
on Quality & Safety
Initiatives
The following report is proprietary information and constitutes trade secrets of The MetroHealth System and may
not be disclosed in whole or part to any external parties without the express consent of The MetroHealth
System. This document is intended to be used internally for MetroHealth System discussion.
Dual Sign
Why Dual Sign?
• Joint Commission and Institute
for Safe Medication Practices
require dual signoff for highalert medications
• Patient Safety with High Risk
Drugs
• Nationwide Approaches to
improve safety
Levels of Dual Sign at
MetroHealth
• Medication Level (ERX)
– Medication in all locations
– Heparin
• Profile Level
– Nursing Students
• Department Level – Global
– Medications given at a certain
area - NICU
• Department – Drug Specific
– Certain medications
– Certain departments
• MAR Action – Exclusions
– Specific Mar actions can be
excluded from requirement
!! Symbol = Dual Signoff Required
Outcomes: Significant Heparin Errors
Barcode Medication Administration: BCMA
Why BCMA?
• Patient Safety Initiative
• U.S Department of Health &
Human Services
– “Errors associated with
medications are the most frequent
cause of adverse medical events”
• Meaningful Use: Stage 2
Requirement
• HIMSS Stage 6
–
•
Closed loop mediation
administration
HIMSS Stage 7:
–
–
Expressed Breast Milk
Blood Products
Patient & Medication Scanning Compliance
Best Practice Alerts: BPA
What are BPAs?
MetroHealth Examples
• Provide targeted, patientspecific clinical guidance to
end-users
• Versatile decision support tool
• Scan patient’s entire record
• Display notifications based on
key pieces of clinical data
• Ebola Screening
–
–
–
–
–
Lab results
Assessment data
Medications
Diagnoses
Histories
• Include links to actions
– Order placement
– Care plans
– Identifying patient’s at risk
– Alerting clinical team members
• Immunizations
– Screening reminders
– Order placement
– Administration reminders
• Heart Failure Discharge
Instructions
– Reminder based on Problem List
• VTE Risk Assessment
– Assessment reminder
– Contraindication documentation
• Restraints
– Incorporate Care Plan